Molecular Obstacles to Clinical Translation of iPSCs

Cell Stem Cell

Volumn 19, Issue 3, 2016, Pages 298-309

  Tapia, Natalia ^a   Schöler, Hans R ^b,c  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELLULAR IMMUNITY; EPIGENETICS; GENETIC BACKGROUND; GENETIC STABILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROGENY; REVIEW; SOMATIC CELL; ANIMAL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; IMMUNITY; TRANSLATIONAL RESEARCH;

ANIMALS; CELLULAR REPROGRAMMING; EPIGENESIS, GENETIC; GENOMIC INSTABILITY; HUMANS; IMMUNITY; INDUCED PLURIPOTENT STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84991085076     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2016.06.017     Document Type: Review

References (96)

1. Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502 (2013), 340–345.
2. Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M.S., Tomasini, L., Ferrandino, A.F., Rosenberg Belmaker, L.A., Szekely, A., Wilson, M., et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492 (2012), 438–442.
3. Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A., Abe, M., Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494 (2013), 100–104.
4. Bar-Nur, O., Brumbaugh, J., Verheul, C., Apostolou, E., Pruteanu-Malinici, I., Walsh, R.M., Ramaswamy, S., Hochedlinger, K., Small molecules facilitate rapid and synchronous iPSC generation. Nat. Methods 11 (2014), 1170–1176.
5. Bhutani, K., Nazor, K.L., Williams, R., Tran, H., Dai, H., Džakula, Ž., Cho, E.H., Pang, A.W., Rao, M., Cao, H., et al. Whole-genome mutational burden analysis of three pluripotency induction methods. Nat. Commun., 7, 2016, 10536.
6. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller, M., Croft, G.F., Amoroso, M.W., Oakley, D.H., et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144 (2011), 439–452.
7. Buganim, Y., Faddah, D.A., Cheng, A.W., Itskovich, E., Markoulaki, S., Ganz, K., Klemm, S.L., van Oudenaarden, A., Jaenisch, R., Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150 (2012), 1209–1222.
8. Buganim, Y., Markoulaki, S., van Wietmarschen, N., Hoke, H., Wu, T., Ganz, K., Akhtar-Zaidi, B., He, Y., Abraham, B.J., Porubsky, D., et al. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell 15 (2014), 295–309.
9. Carey, B.W., Markoulaki, S., Hanna, J.H., Faddah, D.A., Buganim, Y., Kim, J., Ganz, K., Steine, E.J., Cassady, J.P., Creyghton, M.P., et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9 (2011), 588–598.
10. Chan, M.M., Smith, Z.D., Egli, D., Regev, A., Meissner, A., Mouse ooplasm confers context-specific reprogramming capacity. Nat. Genet. 44 (2012), 978–980.
11. Chantzoura, E., Skylaki, S., Menendez, S., Kim, S.I., Johnsson, A., Linnarsson, S., Woltjen, K., Chambers, I., Kaji, K., Reprogramming Roadblocks Are System Dependent. Stem Cell Reports 5 (2015), 350–364.
12. Chen, J., Liu, H., Liu, J., Qi, J., Wei, B., Yang, J., Liang, H., Chen, Y., Chen, J., Wu, Y., et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 45 (2013), 34–42.
13. Cheng, L., Hansen, N.F., Zhao, L., Du, Y., Zou, C., Donovan, F.X., Chou, B.K., Zhou, G., Li, S., Dowey, S.N., et al., NISC Comparative Sequencing Program. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10 (2012), 337–344.
14. Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5 (2009), 111–123.
15. Chin, M.H., Pellegrini, M., Plath, K., Lowry, W.E., Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7 (2010), 263–269.
16. Choi, J., Lee, S., Mallard, W., Clement, K., Tagliazucchi, G.M., Lim, H., Choi, I.Y., Ferrari, F., Tsankov, A.M., Pop, R., et al. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nat. Biotechnol. 33 (2015), 1173–1181.
17. Chung, Y.G., Eum, J.H., Lee, J.E., Shim, S.H., Sepilian, V., Hong, S.W., Lee, Y., Treff, N.R., Choi, Y.H., Kimbrel, E.A., et al. Human somatic cell nuclear transfer using adult cells. Cell Stem Cell 14 (2014), 777–780.
18. Chung, Y.G., Matoba, S., Liu, Y., Eum, J.H., Lu, F., Jiang, W., Lee, J.E., Sepilian, V., Cha, K.Y., Lee, D.R., Zhang, Y., Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells. Cell Stem Cell 17 (2015), 758–766.
19. de Almeida, P.E., Meyer, E.H., Kooreman, N.G., Diecke, S., Dey, D., Sanchez-Freire, V., Hu, S., Ebert, A., Odegaard, J., Mordwinkin, N.M., et al. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat. Commun., 5, 2014, 3903.
20. Deuse, T., Wang, D., Stubbendorff, M., Itagaki, R., Grabosch, A., Greaves, L.C., Alawi, M., Grünewald, A., Hu, X., Hua, X., et al. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. Cell Stem Cell 16 (2015), 33–38.
21. Doi, A., Park, I.H., Wen, B., Murakami, P., Aryee, M.J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41 (2009), 1350–1353.
22. dos Santos, R.L., Tosti, L., Radzisheuskaya, A., Caballero, I.M., Kaji, K., Hendrich, B., Silva, J.C., MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner. Cell Stem Cell 15 (2014), 102–110.
23. Egli, D., Chen, A.E., Saphier, G., Ichida, J., Fitzgerald, C., Go, K.J., Acevedo, N., Patel, J., Baetscher, M., Kearns, W.G., et al. Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nat. Commun., 2, 2011, 488.
24. Gao, Y., Chen, J., Li, K., Wu, T., Huang, B., Liu, W., Kou, X., Zhang, Y., Huang, H., Jiang, Y., et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12 (2013), 453–469.
25. Gao, S., Zheng, C., Chang, G., Liu, W., Kou, X., Tan, K., Tao, L., Xu, K., Wang, H., Cai, J., et al. Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells. Nat. Commun., 6, 2015, 6318.
26. Gaspar-Maia, A., Qadeer, Z.A., Hasson, D., Ratnakumar, K., Leu, N.A., Leroy, G., Liu, S., Costanzi, C., Valle-Garcia, D., Schaniel, C., et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun., 4, 2013, 1565.
27. Ghosh, Z., Wilson, K.D., Wu, Y., Hu, S., Quertermous, T., Wu, J.C., Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE, 5, 2010, e8975.
28. Gonzalez-Muñoz, E., Arboleda-Estudillo, Y., Otu, H.H., Cibelli, J.B., Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. Science 345 (2014), 822–825.
29. Gu, T.P., Guo, F., Yang, H., Wu, H.P., Xu, G.F., Liu, W., Xie, Z.G., Shi, L., He, X., Jin, S.G., et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477 (2011), 606–610.
30. Guenther, M.G., Frampton, G.M., Soldner, F., Hockemeyer, D., Mitalipova, M., Jaenisch, R., Young, R.A., Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7 (2010), 249–257.
31. Guha, P., Morgan, J.W., Mostoslavsky, G., Rodrigues, N.P., Boyd, A.S., Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12 (2013), 407–412.
32. Han, J., Yuan, P., Yang, H., Zhang, J., Soh, B.S., Li, P., Lim, S.L., Cao, S., Tay, J., Orlov, Y.L., et al. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463 (2010), 1096–1100.
33. Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C.J., Creyghton, M.P., van Oudenaarden, A., Jaenisch, R., Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462 (2009), 595–601.
34. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333 (2011), 1303–1307.
35. Hu, B.Y., Weick, J.P., Yu, J., Ma, L.X., Zhang, X.Q., Thomson, J.A., Zhang, S.C., Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. USA 107 (2010), 4335–4340.
36. Hu, X., Zhang, L., Mao, S.Q., Li, Z., Chen, J., Zhang, R.R., Wu, H.P., Gao, J., Guo, F., Liu, W., et al. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. Cell Stem Cell 14 (2014), 512–522.
37. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., Melton, D.A., Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26 (2008), 795–797.
38. Hussein, S.M., Batada, N.N., Vuoristo, S., Ching, R.W., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471 (2011), 58–62.
39. Jiang, J., Lv, W., Ye, X., Wang, L., Zhang, M., Yang, H., Okuka, M., Zhou, C., Zhang, X., Liu, L., Li, J., Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Res. 23 (2013), 92–106.
40. Johannesson, B., Sagi, I., Gore, A., Paull, D., Yamada, M., Golan-Lev, T., Li, Z., LeDuc, C., Shen, Y., Stern, S., et al. Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell 15 (2014), 634–642.
41. Kang, E., Wang, X., Tippner-Hedges, R., Ma, H., Folmes, C.D.L., Marti Gutierrez, N., Lee, Y., Van Dyken, C., Ahmed, R., Li, Y., et al. Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell 18 (2016), 1–12.
42. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji, H., Ehrlich, L.I., et al. Epigenetic memory in induced pluripotent stem cells. Nature 467 (2010), 285–290.
43. Kishigami, S., Mizutani, E., Ohta, H., Hikichi, T., Thuan, N.V., Wakayama, S., Bui, H.T., Wakayama, T., Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem. Biophys. Res. Commun. 340 (2006), 183–189.
44. Klawitter, S., Fuchs, N.V., Upton, K.R., Muñoz-Lopez, M., Shukla, R., Wang, J., Garcia-Cañadas, M., Lopez-Ruiz, C., Gerhardt, D.J., Sebe, A., et al. Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nat. Commun., 7, 2016, 10286.
45. Ko, K., Tapia, N., Wu, G., Kim, J.B., Bravo, M.J., Sasse, P., Glaser, T., Ruau, D., Han, D.W., Greber, B., et al. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell 5 (2009), 87–96.
46. Ko, K., Wu, G., Araúzo-Bravo, M.J., Kim, J., Francine, J., Greber, B., Mühlisch, J., Joo, J.Y., Sabour, D., Frühwald, M.C., et al. Autologous pluripotent stem cells generated from adult mouse testicular biopsy. Stem Cell Rev. 8 (2012), 435–444.
47. Krijger, P.H., Di Stefano, B., de Wit, E., Limone, F., van Oevelen, C., de Laat, W., Graf, T., Cell-of-origin-specific 3D genome structure acquired during somatic cell reprogramming. Cell Stem Cell 18 (2016), 597–610.
48. Kyttälä, A., Moraghebi, R., Valensisi, C., Kettunen, J., Andrus, C., Pasumarthy, K.K., Nakanishi, M., Nishimura, K., Ohtaka, M., Weltner, J., et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports 6 (2016), 200–212.
49. Laurent, L.C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J.V., Lee, S., Barrero, M.J., et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8 (2011), 106–118.
50. Le, R., Kou, Z., Jiang, Y., Li, M., Huang, B., Liu, W., Li, H., Kou, X., He, W., Rudolph, K.L., et al. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells. Cell Stem Cell 14 (2014), 27–39.
51. Li, Z., Lu, H., Yang, W., Yong, J., Zhang, Z.N., Zhang, K., Deng, H., Xu, Y., Mouse SCNT ESCs have lower somatic mutation load than syngeneic iPSCs. Stem Cell Reports 2 (2014), 399–405.
52. Liang, G., Zhang, Y., Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13 (2013), 149–159.
53. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471 (2011), 68–73.
54. Lujan, E., Zunder, E.R., Ng, Y.H., Goronzy, I.N., Nolan, G.P., Wernig, M., Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature 521 (2015), 352–356.
55. Ma, H., Morey, R., O'Neil, R.C., He, Y., Daughtry, B., Schultz, M.D., Hariharan, M., Nery, J.R., Castanon, R., Sabatini, K., et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 511 (2014), 177–183.
56. Marion, R.M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M., Blasco, M.A., Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4 (2009), 141–154.
57. Marthaler, A.G., Tiemann, U., Araúzo-Bravo, M.J., Wu, G., Zaehres, H., Hyun, J.K., Han, D.W., Schöler, H.R., Tapia, N., Reprogramming to pluripotency through a somatic stem cell intermediate. PLoS ONE, 8, 2013, e85138.
58. Matoba, S., Liu, Y., Lu, F., Iwabuchi, K.A., Shen, L., Inoue, A., Zhang, Y., Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell 159 (2014), 884–895.
59. Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.C., Yakir, B., Clark, A.T., Plath, K., Lowry, W.E., Benvenisty, N., Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7 (2010), 521–531.
60. Mertens, J., Paquola, A.C., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J.R., et al. Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. Cell Stem Cell 17 (2015), 705–718.
61. Müller, F.J., Schuldt, B.M., Williams, R., Mason, D., Altun, G., Papapetrou, E.P., Danner, S., Goldmann, J.E., Herbst, A., Schmidt, N.O., et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8 (2011), 315–317.
62. O'Malley, J., Skylaki, S., Iwabuchi, K.A., Chantzoura, E., Ruetz, T., Johnsson, A., Tomlinson, S.R., Linnarsson, S., Kaji, K., High-resolution analysis with novel cell-surface markers identifies routes to iPS cells. Nature 499 (2013), 88–91.
63. Okita, K., Nagata, N., Yamanaka, S., Immunogenicity of induced pluripotent stem cells. Circ. Res. 109 (2011), 720–721.
64. Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato, Y., Cowan, C.A., Chien, K.R., Melton, D.A., Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26 (2008), 313–315.
65. Peterson, S.E., Loring, J.F., Genomic instability in pluripotent stem cells: implications for clinical applications. J. Biol. Chem. 289 (2014), 4578–4584.
66. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28 (2010), 848–855.
67. Polo, J.M., Anderssen, E., Walsh, R.M., Schwarz, B.A., Nefzger, C.M., Lim, S.M., Borkent, M., Apostolou, E., Alaei, S., Cloutier, J., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151 (2012), 1617–1632.
68. Pyle, A.D., Lock, L.F., Donovan, P.J., Neurotrophins mediate human embryonic stem cell survival. Nat. Biotechnol. 24 (2006), 344–350.
69. Quinlan, A.R., Boland, M.J., Leibowitz, M.L., Shumilina, S., Pehrson, S.M., Baldwin, K.K., Hall, I.M., Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9 (2011), 366–373.
70. Rais, Y., Zviran, A., Geula, S., Gafni, O., Chomsky, E., Viukov, S., Mansour, A.A., Caspi, I., Krupalnik, V., Zerbib, M., et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 502 (2013), 65–70.
71. Rouhani, F., Kumasaka, N., de Brito, M.C., Bradley, A., Vallier, L., Gaffney, D., Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet., 10, 2014, e1004432.
72. Shen, L., Inoue, A., He, J., Liu, Y., Lu, F., Zhang, Y., Tet3 and DNA replication mediate demethylation of both the maternal and paternal genomes in mouse zygotes. Cell Stem Cell 15 (2014), 459–470.
73. Shinagawa, T., Takagi, T., Tsukamoto, D., Tomaru, C., Huynh, L.M., Sivaraman, P., Kumarevel, T., Inoue, K., Nakato, R., Katou, Y., et al. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells. Cell Stem Cell 14 (2014), 217–227.
74. Shu, J., Wu, C., Wu, Y., Li, Z., Shao, S., Zhao, W., Tang, X., Yang, H., Shen, L., Zuo, X., et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 153 (2013), 963–975.
75. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 (2009), 964–977.
76. Taapken, S.M., Nisler, B.S., Newton, M.A., Sampsell-Barron, T.L., Leonhard, K.A., McIntire, E.M., Montgomery, K.D., Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat. Biotechnol. 29 (2011), 313–314.
77. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
78. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
79. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Sasaki, A., Yamamoto, M., Nakamura, M., Sutou, K., Osafune, K., Yamanaka, S., Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat. Commun., 5, 2014, 3678.
80. Tang, C., Drukker, M., Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Semin. Immunopathol. 33 (2011), 563–572.
81. Tiemann, U., Marthaler, A.G., Adachi, K., Wu, G., Fischedick, G.U., Araúzo-Bravo, M.J., Schöler, H.R., Tapia, N., Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotency. Stem Cell Reports 2 (2014), 351–365.
82. Tiemann, U., Wu, G., Marthaler, A.G., Schöler, H.R., Tapia, N., Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming. Stem Cell Reports 6 (2016), 35–43.
83. van Echten, J., Oosterhuis, J.W., Looijenga, L.H., van de Pol, M., Wiersema, J., te Meerman, G.J., Schaffordt Koops, H., Sleijfer, D.T., de Jong, B., No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer 14 (1995), 133–144.
84. Varela, C., Denis, J.A., Polentes, J., Feyeux, M., Aubert, S., Champon, B., Piétu, G., Peschanski, M., Lefort, N., Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J. Clin. Invest. 122 (2012), 569–574.
85. Vidal, S.E., Amlani, B., Chen, T., Tsirigos, A., Stadtfeld, M., Combinatorial modulation of signaling pathways reveals cell-type-specific requirements for highly efficient and synchronous iPSC reprogramming. Stem Cell Reports 3 (2014), 574–584.
86. Wakayama, S., Kohda, T., Obokata, H., Tokoro, M., Li, C., Terashita, Y., Mizutani, E., Nguyen, V.T., Kishigami, S., Ishino, F., Wakayama, T., Successful serial recloning in the mouse over multiple generations. Cell Stem Cell 12 (2013), 293–297.
87. Wood, K.J., Issa, F., Hester, J., Understanding Stem Cell Immunogenicity in Therapeutic Applications. Trends Immunol. 37 (2016), 5–16.
88. Wu, G., Han, D., Gong, Y., Sebastiano, V., Gentile, L., Singhal, N., Adachi, K., Fischedick, G., Ortmeier, C., Sinn, M., et al. Establishment of totipotency does not depend on Oct4A. Nat. Cell Biol. 15 (2013), 1089–1097.
89. Wu, T., Liu, Y., Wen, D., Tseng, Z., Tahmasian, M., Zhong, M., Rafii, S., Stadtfeld, M., Hochedlinger, K., Xiao, A., Histone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs. Cell Stem Cell 15 (2014), 281–294.
90. Yamanaka, S., Elite and stochastic models for induced pluripotent stem cell generation. Nature 460 (2009), 49–52.
91. Yamanaka, S., Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10 (2012), 678–684.
92. Young, M.A., Larson, D.E., Sun, C.W., George, D.R., Ding, L., Miller, C.A., Lin, L., Pawlik, K.M., Chen, K., Fan, X., et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10 (2012), 570–582.
93. Zhao, X.Y., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C.L., Ma, Q.W., Wang, L., et al. iPS cells produce viable mice through tetraploid complementation. Nature 461 (2009), 86–90.
94. Zhao, T., Zhang, Z.N., Rong, Z., Xu, Y., Immunogenicity of induced pluripotent stem cells. Nature 474 (2011), 212–215.
95. Zhao, T., Zhang, Z.N., Westenskow, P.D., Todorova, D., Hu, Z., Lin, T., Rong, Z., Kim, J., He, J., Wang, M., et al. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells. Cell Stem Cell 17 (2015), 353–359.
96. Zunder, E.R., Lujan, E., Goltsev, Y., Wernig, M., Nolan, G.P., A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. Cell Stem Cell 16 (2015), 323–337.